The White House has proposed a sweeping overhaul of the federal response to HIV, calling for a FY 2027 budget request that would significantly reduce funding for several cornerstone domestic HIV programs. Released on April 3, 2026, the proposal marks a sharp departure from previous funding trajectories, representing a $1.6 billion, or 35%, decline in domestic HIV program funding compared to the final levels of fiscal year 2026.
The proposal seeks to consolidate the federal HIV apparatus by moving programs from the Health Resources and Services Administration (HRSA) and other agencies into a proposed new entity called the Administration for Healthy America (AHA). While the administration asserts that this new agency will prioritize HIV/AIDS programs to align with its specific goals, the structural shift coincides with the proposed elimination of several historical prevention and support initiatives.
As a physician, I have seen how the stability of federal funding translates directly into patient care on the ground. When grants are delayed or eliminated, the ripple effect hits community clinics and marginalized populations first. The current request targets not only the budget for the coming year but also the infrastructure of prevention, research, and housing that has supported millions of Americans living with HIV.
a presidential budget request is a statement of priority, not a final law. Congress maintains the “power of the purse” and is responsible for the actual appropriation of funds. This tension was evident in the previous cycle; although President Trump called for reduced HIV funding in the FY 2026 request, Congress ultimately appropriated funding levels similar to those of the prior year.
The Impact on Prevention and Research
One of the most significant shifts in the FY 2027 request is the proposed elimination of core HIV prevention programs at the Centers for Disease Control and Prevention (CDC). Historically, the CDC has provided approximately 91% of all federal funding for domestic HIV prevention. The proposal would eliminate these core funds, representing a $794 million decrease over FY 2026 levels.
The only CDC prevention funding preserved is the $220 million allocated for the Ending the HIV Epidemic (EHE) initiative, which would be moved to the new AHA agency. The administration has proposed grouping separate funding lines for viral hepatitis, sexually transmitted infections (STIs), and tuberculosis into a single $300 million account—a $70 million reduction from the combined total of those individual accounts in FY 2026.
The scientific community also faces a steep decline in support. The budget proposes significant cuts to the National Institutes of Health (NIH), specifically targeting the National Institute of Allergy and Infectious Diseases (NIAID). The request would cut NIAID funding by $1.8 billion, or 27%, reducing it from approximately $6.5 billion to $4.8 billion. Given that NIAID has been the world’s largest source of HIV research funding, these cuts could slow the development of new treatments and a potential cure.
Threats to the Safety Net and Housing
The Ryan White HIV/AIDS Program, which serves as the primary safety net for care and treatment in the U.S., would see its funding drop to $2.5 billion, a $74 million decrease from FY 2026 enacted levels. This reduction is primarily driven by the total elimination of “Part F” of the program.
The loss of Part F funding would impact three critical areas of care:
- Provider Education: The AIDS Education and Training Centers (AETCs) provide essential training for clinicians treating HIV.
- Oral Health: The Dental Reimbursement Program and the Community-Based Dental Partnership Program expand access to specialized dental care for people living with HIV.
- Equity Initiatives: The Minority AIDS Initiative (MAI), created in 1998 to address the disproportionate impact of HIV on racial and ethnic minorities, would see its funding eliminated across multiple channels, including SAMHSA and the Secretary’s Minority HIV/AIDS funds.
Beyond clinical care, the proposal eliminates the Housing Opportunities for People with AIDS (HOPWA) program entirely. Established in 1992, HOPWA is the only federal program dedicated specifically to the housing needs of low-income people living with HIV. In FY 2026, this program was funded at $529 million; its removal would leave a critical gap for those facing housing insecurity, which is often a primary barrier to maintaining medication adherence and health stability.
Administrative Actions and Systemic Uncertainty
The budget request is only one part of a broader strategy. The administration has utilized executive actions to limit or terminate already appropriated funds by delaying or canceling grants. These maneuvers have led to legal challenges, including litigation by the California Attorney General to protect health funding, some of which resulted in the temporary reinstatement of grants.
The administration has also attempted the rescission process—asking Congress to take back funds that have already been appropriated. While these rescissions have not yet impacted domestic HIV accounts, the combination of proposed cuts and executive delays has created a climate of uncertainty for grantees and sub-grantees. This instability makes long-term planning nearly impossible for the community-based organizations that provide the actual care.
This financial volatility occurs alongside other policy shifts. Changes to the health policy landscape, including potential modifications to Medicaid and the expiration of certain tax credits, may further restrict access to HIV care and prevention services, such as Pre-Exposure Prophylaxis (PrEP), which was notably absent from the administration’s proposals to bolster uptake.
Summary of Major Proposed Funding Changes
| Program/Agency | FY 2026 Level | FY 2027 Request | Change |
|---|---|---|---|
| CDC Core Prevention | ~$1 Billion | $0 | Eliminated |
| HOPWA (Housing) | $529 Million | $0 | Eliminated |
| Ryan White Program | ~$2.57 Billion | $2.5 Billion | -$74 Million |
| NIAID (NIH) | ~$6.5 Billion | $4.8 Billion | -$1.8 Billion |
Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice.
The next critical phase will be the Congressional appropriations process. Lawmakers will now evaluate the administration’s request and determine the final funding levels for the 2027 fiscal year. The outcome will depend on whether Congress chooses to follow the administration’s consolidation and reduction strategy or maintain the funding levels established in previous years.
We invite you to share this report and join the conversation in the comments below regarding the future of public health funding.
